Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Ischemia | 14 | 2024 | 311 | 1.740 |
Why?
|
Stroke | 20 | 2024 | 1058 | 1.640 |
Why?
|
Thrombectomy | 13 | 2024 | 167 | 1.440 |
Why?
|
Registries | 14 | 2024 | 2209 | 0.780 |
Why?
|
Endovascular Procedures | 8 | 2024 | 471 | 0.770 |
Why?
|
Stents | 8 | 2024 | 999 | 0.430 |
Why?
|
Cerebral Revascularization | 3 | 2015 | 25 | 0.360 |
Why?
|
Reperfusion | 3 | 2021 | 25 | 0.310 |
Why?
|
Mechanical Thrombolysis | 3 | 2017 | 12 | 0.290 |
Why?
|
Pseudotumor Cerebri | 1 | 2022 | 62 | 0.200 |
Why?
|
Cerebral Infarction | 2 | 2024 | 72 | 0.190 |
Why?
|
Tissue Plasminogen Activator | 2 | 2019 | 161 | 0.180 |
Why?
|
North America | 6 | 2018 | 338 | 0.180 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2018 | 43 | 0.150 |
Why?
|
Treatment Outcome | 17 | 2024 | 33756 | 0.150 |
Why?
|
Intracranial Hemorrhages | 1 | 2018 | 120 | 0.140 |
Why?
|
Postoperative Hemorrhage | 1 | 2018 | 135 | 0.140 |
Why?
|
Thrombolytic Therapy | 1 | 2019 | 250 | 0.140 |
Why?
|
Fibrinolytic Agents | 1 | 2019 | 293 | 0.140 |
Why?
|
Cerebral Hemorrhage | 1 | 2018 | 190 | 0.140 |
Why?
|
Catheterization | 1 | 2019 | 418 | 0.140 |
Why?
|
Patient Transfer | 1 | 2017 | 138 | 0.130 |
Why?
|
Early Medical Intervention | 1 | 2016 | 32 | 0.130 |
Why?
|
Cerebral Angiography | 4 | 2019 | 148 | 0.130 |
Why?
|
Prospective Studies | 9 | 2024 | 13420 | 0.130 |
Why?
|
Betacoronavirus | 1 | 2020 | 513 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 2654 | 0.120 |
Why?
|
Ischemia | 1 | 2017 | 403 | 0.120 |
Why?
|
Aged, 80 and over | 13 | 2024 | 31037 | 0.120 |
Why?
|
Anesthesia, Local | 1 | 2014 | 64 | 0.110 |
Why?
|
Intracranial Aneurysm | 1 | 2014 | 129 | 0.110 |
Why?
|
Cerebrovascular Circulation | 2 | 2013 | 514 | 0.110 |
Why?
|
Coronavirus Infections | 1 | 2020 | 625 | 0.100 |
Why?
|
Anesthesia, General | 1 | 2014 | 222 | 0.100 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 700 | 0.100 |
Why?
|
Aged | 17 | 2024 | 73417 | 0.100 |
Why?
|
Catheterization, Central Venous | 1 | 2013 | 363 | 0.090 |
Why?
|
Male | 18 | 2024 | 128463 | 0.080 |
Why?
|
Infarction, Middle Cerebral Artery | 2 | 2020 | 43 | 0.080 |
Why?
|
Middle Aged | 15 | 2024 | 90382 | 0.080 |
Why?
|
Embolization, Therapeutic | 1 | 2014 | 605 | 0.080 |
Why?
|
Female | 18 | 2024 | 149029 | 0.080 |
Why?
|
Surveys and Questionnaires | 1 | 2020 | 5927 | 0.070 |
Why?
|
Humans | 25 | 2024 | 270880 | 0.070 |
Why?
|
Retrospective Studies | 9 | 2022 | 39865 | 0.070 |
Why?
|
Flank Pain | 1 | 2005 | 10 | 0.060 |
Why?
|
Thoracic Injuries | 1 | 2005 | 99 | 0.060 |
Why?
|
Wounds, Nonpenetrating | 1 | 2005 | 224 | 0.060 |
Why?
|
Spleen | 1 | 2005 | 726 | 0.050 |
Why?
|
Cohort Studies | 4 | 2018 | 9475 | 0.050 |
Why?
|
Middle Cerebral Artery | 1 | 2020 | 113 | 0.040 |
Why?
|
Microfilament Proteins | 1 | 2002 | 494 | 0.040 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2018 | 7 | 0.040 |
Why?
|
Basilar Artery | 1 | 2018 | 28 | 0.040 |
Why?
|
Vertebral Artery | 1 | 2018 | 33 | 0.040 |
Why?
|
Carotid Artery, Internal | 1 | 2018 | 81 | 0.040 |
Why?
|
Intensive Care Units | 1 | 2022 | 738 | 0.040 |
Why?
|
Neurosurgical Procedures | 1 | 2022 | 633 | 0.040 |
Why?
|
Forecasting | 1 | 2020 | 702 | 0.040 |
Why?
|
United States | 3 | 2020 | 15864 | 0.040 |
Why?
|
Carotid Artery Diseases | 1 | 2018 | 176 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 4963 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2022 | 855 | 0.030 |
Why?
|
Time-to-Treatment | 1 | 2017 | 307 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2016 | 237 | 0.030 |
Why?
|
Cell Movement | 1 | 2002 | 2472 | 0.030 |
Why?
|
Hospitals | 1 | 2017 | 484 | 0.030 |
Why?
|
Intracranial Thrombosis | 1 | 2013 | 19 | 0.030 |
Why?
|
Risk Factors | 3 | 2015 | 17902 | 0.030 |
Why?
|
Mortality | 1 | 2015 | 347 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2016 | 554 | 0.030 |
Why?
|
Time Factors | 2 | 2017 | 13023 | 0.030 |
Why?
|
Regression Analysis | 1 | 2015 | 1571 | 0.020 |
Why?
|
Pandemics | 1 | 2020 | 1611 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 9290 | 0.020 |
Why?
|
Rib Fractures | 1 | 2005 | 38 | 0.020 |
Why?
|
Age Factors | 1 | 2014 | 5465 | 0.020 |
Why?
|
Abdominal Injuries | 1 | 2005 | 122 | 0.010 |
Why?
|
Emergency Medicine | 1 | 2005 | 159 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 4375 | 0.010 |
Why?
|
Tensins | 1 | 2002 | 3 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 2002 | 210 | 0.010 |
Why?
|
3T3 Cells | 1 | 2002 | 384 | 0.010 |
Why?
|
Molecular Weight | 1 | 2002 | 721 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2002 | 300 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 15223 | 0.010 |
Why?
|
Radiography | 1 | 2005 | 1988 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2002 | 264 | 0.010 |
Why?
|
Multigene Family | 1 | 2002 | 469 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2002 | 938 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2002 | 929 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2002 | 1082 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2002 | 693 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2014 | 5682 | 0.010 |
Why?
|
Exons | 1 | 2002 | 1383 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 1642 | 0.010 |
Why?
|
Young Adult | 1 | 2014 | 22245 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2002 | 4569 | 0.010 |
Why?
|
Base Sequence | 1 | 2002 | 5437 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 6686 | 0.010 |
Why?
|
Adult | 2 | 2014 | 82036 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2002 | 6398 | 0.010 |
Why?
|
Adolescent | 1 | 2005 | 32770 | 0.000 |
Why?
|
Child | 1 | 2005 | 30568 | 0.000 |
Why?
|
Mice | 1 | 2002 | 35598 | 0.000 |
Why?
|
Animals | 1 | 2002 | 62051 | 0.000 |
Why?
|